Lymphocyte percentage decreased
(UMLS:C0949044)
- UMLS ID:
- C0949044
- MeSH ID:
- N/A
Synonym(s)
1.
Lymphocyte percentage decreased
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Fingolimod Hydrochloride | FAERS: 40 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 2 | Clozapine | FAERS: 14 | US FAERS | |
| 3 | 4-Aminopyridine | FAERS: 10 | US FAERS | |
| 4 | Dimethyl Fumarate | FAERS: 6 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 5 | Carbamazepine | FAERS: 4 | US FAERS | |
| 6 | Isotretinoin | FAERS: 4 | US FAERS | |
| 7 | Ruxolitinib phosphate | FAERS: 3 | US FAERS | |
| 8 | rofecoxib | FAERS: 3 | US FAERS | |
| 9 | Atorvastatin | FAERS: 2 | US FAERS | |
| 10 | Lamotrigine | FAERS: 2 | US FAERS | |
| 11 | Mesalamine | FAERS: 2 | US FAERS | |
| 12 | Mirtazapine | FAERS: 2 | US FAERS | |
| 13 | NuvaRing | FAERS: 2 | US FAERS | |
| 14 | Sertraline | FAERS: 2 | US FAERS | |
| 15 | Terbinafine | FAERS: 2 | US FAERS | |
| 16 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 1 | US FAERS | |
| 17 | Amlodipine | FAERS: 1 | US FAERS | |
| 18 | Aripiprazole | FAERS: 1 | US FAERS | |
| 19 | Atomoxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 20 | Baclofen | FAERS: 1 | US FAERS | |
| 21 | Bortezomib | FAERS: 1 | US FAERS | |
| 22 | Cabozantinib S-malate | FAERS: 1 | US FAERS | |
| 23 | Cladribine | FAERS: 1 | US FAERS | |
| 24 | Doxycycline | FAERS: 1 | US FAERS | |
| 25 | Duloxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 26 | Everolimus | FAERS: 1 | US FAERS | |
| 27 | Fluoxetine | FAERS: 1 | US FAERS | |
| 28 | Fluticasone | FAERS: 1 | US FAERS | |
| 29 | Ibuprofen | FAERS: 1 | OFFSIDES US FAERS | |
| 30 | Levofloxacin | FAERS: 1 | US FAERS | |
| 31 | Loxapine | FAERS: 1 | US FAERS | |
| 32 | Methotrexate | FAERS: 1 | OFFSIDES US FAERS | |
| 33 | Metronidazole | FAERS: 1 | US FAERS | |
| 34 | Olanzapine | FAERS: 1 | US FAERS | |
| 35 | Prednisolone | FAERS: 1 | US FAERS | |
| 36 | Rivastigmine | FAERS: 1 | US FAERS | |
| 37 | Rolapitant hydrochloride | FAERS: 1 | US FAERS | |
| 38 | Sertraline | FAERS: 1 | US FAERS | |
| 39 | Venlafaxine Hydrochloride | FAERS: 1 | US FAERS | |
| 40 | Vincristine | FAERS: 1 | US FAERS | |
| 41 | Warfarin | FAERS: 1 | US FAERS | |
| 42 | eltrombopag | FAERS: 1 | US FAERS | |
| 43 | gamma-Aminobutyric Acid | FAERS: 1 | US FAERS | |
| 44 | gemcitabine | FAERS: 1 | US FAERS | |
| 45 | iopromide | FAERS: 1 | US FAERS | |
| 46 | liposomal amphotericin B | FAERS: 1 | US FAERS | |
| 47 | pazopanib | FAERS: 1 | US FAERS | |
| 48 | telotristat ethyl | FAERS: 1 | US FAERS | |
| 49 | teriflunomide | FAERS: 1 | US FAERS | |
| 50 | Actarit | OFFSIDES | ||
| 51 | Ambroxol | OFFSIDES | ||
| 52 | Beclomethasone | OFFSIDES | ||
| 53 | Calcium Citrate | OFFSIDES | ||
| 54 | Calcium Compounds | OFFSIDES | ||
| 55 | Carisoprodol | OFFSIDES | ||
| 56 | Caspofungin | OFFSIDES | ||
| 57 | Caspofungin | OFFSIDES | ||
| 58 | Cefepime | OFFSIDES | ||
| 59 | Cefotiam | OFFSIDES | ||
| 60 | Ceftriaxone | OFFSIDES | ||
| 61 | Chlorpromazine | OFFSIDES | ||
| 62 | Cyproheptadine | OFFSIDES | ||
| 63 | Dexamethasone | OFFSIDES | ||
| 64 | Diphenoxylate | OFFSIDES | ||
| 65 | Dyphylline | OFFSIDES | ||
| 66 | Estrogens, Conjugated (USP) | OFFSIDES | ||
| 67 | Ethambutol | OFFSIDES | ||
| 68 | Etodolac | OFFSIDES | ||
| 69 | Etoposide | OFFSIDES | ||
| 70 | Famotidine | OFFSIDES | ||
| 71 | Felbinac | OFFSIDES | ||
| 72 | Flunitrazepam | OFFSIDES | ||
| 73 | Flurazepam | OFFSIDES | ||
| 74 | Fondaparinux | OFFSIDES | ||
| 75 | Formoterol Fumarate | OFFSIDES | ||
| 76 | Foscarnet | OFFSIDES | ||
| 77 | Fulvestrant | OFFSIDES | ||
| 78 | Glipizide | OFFSIDES | ||
| 79 | Glycyrrhizic Acid | OFFSIDES | ||
| 80 | Hydron;carbonate | OFFSIDES | ||
| 81 | Imipenem | OFFSIDES | ||
| 82 | Leflunomide | OFFSIDES | ||
| 83 | Magnesium | OFFSIDES | ||
| 84 | Meropenem | OFFSIDES | ||
| 85 | Methotrimeprazine | OFFSIDES | ||
| 86 | Minocycline | OFFSIDES | ||
| 87 | Misoprostol | OFFSIDES | ||
| 88 | Nateglinide | OFFSIDES | ||
| 89 | Nitroglycerin | OFFSIDES | ||
| 90 | Nizatidine | OFFSIDES | ||
| 91 | Penicillamine | OFFSIDES | ||
| 92 | Phenobarbital | OFFSIDES | ||
| 93 | Piperacillin | OFFSIDES | ||
| 94 | Piroxicam | OFFSIDES | ||
| 95 | Pyrazinamide | OFFSIDES | ||
| 96 | Pyridoxal Phosphate | OFFSIDES | ||
| 97 | Selenium | OFFSIDES | ||
| 98 | Silymarin | OFFSIDES | ||
| 99 | Sodium ferric gluconate complex | OFFSIDES | ||
| 100 | Temozolomide | OFFSIDES | ||
| 101 | Thiamine | OFFSIDES | ||
| 102 | Timolol | OFFSIDES | ||
| 103 | Tremorine | OFFSIDES | ||
| 104 | Tretinoin | OFFSIDES | ||
| 105 | Triazolam | OFFSIDES | ||
| 106 | Trimebutine | OFFSIDES | ||
| 107 | Vitamin D | OFFSIDES | ||
| 108 | alfacalcidol | OFFSIDES | ||
| 109 | brotizolam | OFFSIDES | ||
| 110 | bucillamine | OFFSIDES | ||
| 111 | camostat | OFFSIDES | ||
| 112 | cilnidipine | OFFSIDES | ||
| 113 | distigmine | OFFSIDES | ||
| 114 | ebastine | OFFSIDES | ||
| 115 | epalrestat | OFFSIDES | ||
| 116 | etizolam | OFFSIDES | ||
| 117 | fexofenadine | OFFSIDES | ||
| 118 | frovatriptan | OFFSIDES | ||
| 119 | irsogladine | OFFSIDES | ||
| 120 | manidipine | OFFSIDES | ||
| 121 | mecobalamin | OFFSIDES | ||
| 122 | mizoribine | OFFSIDES | ||
| 123 | nilvadipine | OFFSIDES | ||
| 124 | norgestimate, ethinyl estradiol drug combination | OFFSIDES | ||
| 125 | oxatomide | OFFSIDES | ||
| 126 | pazufloxacin | OFFSIDES | ||
| 127 | pirbuterol | OFFSIDES | ||
| 128 | pitavastatin | OFFSIDES | ||
| 129 | plaunotol | OFFSIDES | ||
| 130 | samarium Sm-153 lexidronam | OFFSIDES | ||
| 131 | tizanidine | OFFSIDES | ||
| 132 | tulobuterol | OFFSIDES | ||
| 133 | urapidil | OFFSIDES | ||
| 134 | voglibose | OFFSIDES | ||
| 135 | zaleplon | OFFSIDES | ||
| 136 | zolmitriptan | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.